CrossAssetDataThe Company File
···
FOCL

Edap Tms S.A.

Edap Tms S.A. is classed by the SEC under Electromedical & Electrotherapeutic Apparatus (industry code 3845), based in 69120 Vaulx En Velin, FR. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $71 million and a loss of $29 million (its filed statements).

Product business Electromedical & Electrotherapeutic Apparatus 69120 Vaulx En Velin, FR filings since 1998 5 of 9 filed, 4 estimated
Ask the desk about FOCL → Compare FOCL with ELMD → Price chart on TradingView ↗ Full EDGAR file ↗ Watch FOCL →

Sector peers: ELMDTMDXMDTINMD

5.9/10headline grade
vs its business-model standard
6.4/10past 6.3/10present 4.7/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3845, Electromedical & Electrotherapeutic Apparatus); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 5.9 out of ten, 5 of 9 metrics filed and 4 estimated: past 6.4 out of ten, present 6.3 out of ten, future 4.7 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 8.0 out of ten. No warning events in its filings since 2017. 80th percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 5.5 out of ten. +7.9% a year over 10 filed years; profit years unseen. 55th percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 6.1 out of ten. CrossAssetData estimate 6.1/10, confidence 35 of 100 (one part). 61st percentile among 27 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 4.9 out of ten. Leverage 52%: owes 52¢ per asset dollar. 49th percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 5.8 out of ten. CrossAssetData estimate 5.8/10, confidence 35 of 100 (one part). 58th percentile among 25 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Leadership (present): 9.8 out of ten. CrossAssetData estimate 9.8/10, confidence 35 of 100 (one part). 98th percentile among 25 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Room to expand (future): 4.7 out of ten. bottom 47% of 23 in its family for room to expand. 47th percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 6.4 out of ten. top 36% of 25 in its family for growth drivers. 64th percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 2.1 out of ten. CrossAssetData estimate 2.1/10, confidence 35 of 100 (one part). 21st percentile among 23 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.

The filing record

Newest annual report: Form 10-K filed 2026-03-25 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-14 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-13 (on EDGAR). Newest filing: Form S-8, 2026-09-15. Filings on record since 1998. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: Manufactured Product Other 69%, Parts and Services 16%, HIFU Treatments and Devices Leased 15%. By geography: United States 40%, Asia 28%, Other geographical areas 25%, France 7%. As tagged in its annual report (Form 10-K, filed 2026-03-25).

Who runs it

Rhodes, Ryan (Chief Executive Officer); Mobeck, Kenneth S. (Chief Financial Officer); Dietsch, Francois Mattieu (Chief Accounting Officer); Annen, Steven (SVP, Marketing & Product Mgmt.); Shah, Sanket (General Counsel & Corp Sec); Horn, David R. (director); Levine, Joshua (director); Schulz, Fran (director); Willsey, Lance (director); French, Glendon E. III (director). 10 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.